You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC. (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC. (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-09-10
Court	District Court, D. Delaware	Date Terminated
Cause	15:1126 Patent Infringement	Assigned To
Jury Demand	Plaintiff	Referred To
Patents	10,039,745; 10,154,987; 11,141,405; 6,028,222; 6,977,257; 8,568,747; 8,778,366; 9,463,183; 9,616,096; 9,669,008; 9,808,442; 9,855,214; 9,968,553
Link to Docket	External link to docket

Small Molecule Drugs cited in AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC. (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-12-13	103		Products (Nov. 2003, Rev. 2; and (5) U.S. Patent No. 8,568,747 B1. A POSA would be motivated to combine…Products (Nov. 2003, Rev. 2; and (5) U.S. Patent No. 8,568,747 B1. A POSA would be motivated to combine…. Del.). 5 U.S. Patent Nos. 11,040,023 (“’023 patent”) and 11,141,405 (“’405 patent”) (collectively, …for patent infringement of United States Patent Nos. 11,040,023 (the “’023 patent”) and…“’405 patent”) (collectively the “Patents-in-Suit”) and damages under the patent laws	External link to document
2021-12-21	109		6/2012 Nov. 2, 2017, now Pat. No. 10,039,745, which is a WO WO-2014055667 …Reference-based pricing of prescription drugs: 10,039,745 B2 8/2018 Mosher … O U.S. Pat. No. 10,039,745, issued Aug. 7, 2018), which is a …action for patent infringement of United States Patent Nos. 11,040,023 (the “’023 patent”) and 11,141,405…11,141,405 (the “’405 patent”) (collectively the “Patents-in-Suit”) and damages under the patent laws of the	External link to document
2022-02-24	137	Redacted Document	Thereafter, U.S. Patent Nos. 9,808,442 B2 (“’442 patent,” 18-1962 D.I. 1-1, Compl. Ex. B), 10,039,745 B2 (“’745… or more claims of U.S. Patent No. 11,040,023 (the “’023 patent”) (the “Patent- In-Suit”). Upon information….S. Patent Application No. 17,228,024, which issued as U.S. Patent No. 11,141,405 (“’405 patent”) on…and ’987 patents are patentably indistinct from, and cover essentially the same patentable subject matter…, the ’008 patent. 123. The claims of the Second Wave Patents are patentably indistinct	External link to document
2022-03-24	149	Opening Brief in Support	U.S. Patent No. 10,039,745 (Aug. 7, 2018) ’442 Patent U.S. Patent No. 9,808,442… for Patents) ’008 Patent U.S. Patent No. 9,669,008 (Jun. 6, 2017) ’745 Patent … ’008 Patent, ’745 Patent, ’442 Patent, and ’987 Patent First Suits 18-1962 and 19….S. Patent No. 11,141,405 (Oct. 12, 2021) Third Patents ’023 Patent and ’405 Patent Third…2017) ’987 Patent U.S. Patent No. 10,154,987 (Dec. 18, 2018) First Patents	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.